The World Bank and pharmaceuticals

The World Bank and pharmaceuticals.

Within less than a decade the World Bank has become the largest single source of finance (loans) for health in low and middle income countries as well as a major player in the field of pharmaceuticals. Often 20-50% of the recurrent government health budget in developing countries is used to procure drugs. Drugs are among the most salient and cost-effective elements of health care and often a ke...

Pharmaceuticals and the developing world.

Pharmaceuticals have brought tremendous health beneŽ ts to developing countries, but existing pharmaceuticals are often underused or misused, and pharmaceutical R&D on health problems speciŽ c to poor countries is woefully inadequate. The role of pharmaceuticals and medical technology in improving health in developing countries stands in contrast to the historical experience of the developed co...

The World Bank

Welcome to the 42nd issue of the World Bank Trade Research Electronic Newsletter, a periodic E-mail publication containing abstracts of recent trade working papers, publications and other works. Additional information on the Bank’s Trade Research Team activities can be found on the recent redesigned World Bank Trade Research website (HUhttp://www.econ.worldbank.org/programs/tradeUH). This provi...

The World Bank

The World Bank

World Bank Working Papers are published to communicate the results of the Bank's work to the development community with the least possible delay. The manuscript of this paper therefore has not been prepared in accordance with the procedures appropriate to formally-edited texts. Some sources cited in this paper may be informal documents that are not readily available. The findings, interpretatio...